Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy

Internal and Emergency Medicine

Volumn 2, Issue 1, 2007, Pages 24-28

  Ferro, D ^a,b   Loffredo, L ^a   Polimeni, L ^a   Violi, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

Atrial fibrillation; Ischaemic stroke; Oral anticoagulants

Indexed keywords

ANTICOAGULANT AGENT;

AGED; ARTICLE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; ITALY; MALE; PRESCRIPTION; STATISTICS;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HUMANS; ITALY; MALE; PRESCRIPTIONS, DRUG;

EID: 34249876327     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-007-0005-2     Document Type: Article

References (33)

1. Lip GYH, Hart RG, Conway DSG (2002) Antithrombotic therapy for atrial fibrillation. BMJ 325:1022-1025
2. Albers GW, Dalen JE, Laupacis A et al (2001) Antithrombotic therapy in atrial fibrillation. Chest 119:1948-2068
3. Fuster V, Ryden LE (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. J Am Coll Cardiol 38:1231-1266
4. Wolf PA, Abbott RD, Kannel WB (1987) Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 147:1561-1564
5. _ (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154:1449-1457
6. Hart RG, Benavente O, McBride R, Pearce LA (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131:492-501
7. Hart RG, Halperin JL, Pearce LA et al (2003) Lessons from the stroke prevention in atrial fibrillation trials. Ann Intern Med 138:831-839
8. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B (1989) Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFaSAK study. Lancet 1:175-179
9. _ (1994) Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II study. Lancet 343:687-691
10. Hart RG, Pearce LA, Miller VT et al (2000) Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis 10:39-43
11. Cohen N, Almoznino-Sarafian D, Alon I et al (2000) Warfarin for stroke prevention still underused in atrial fibrillation. Patterns of omission. Stroke 31:1217-1222
12. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT (2000) Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 160:41-46
13. Buckingham TA, Hatala R (2002) Anticoagulants for atrial fibrillation: why is the treatment so low? Clin Cardiol 25:447-454
14. _ (1991) Stroke Prevention in Atrial Fibrillation study. Final results. Circulation 84:527-529
15. _ (1996) Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation ni randomized clinical trial. Lancet 348:633-638
16. _ (1990) The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 323:1505-1511
17. Ezekowitz MD, Bridgers SL, James KE et al (1992) Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 327:1406-1412
18. Brophy MT, Snyder KE, Gaedhe S et al (2004) Anticoagulant use for atrial fibrillation in the elderly. J Am Geriatr Soc 52:1151-1161
19. Rockson SG, Albers GW (2004) Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation. J Am Coll Cardiol 43:929-935
20. Adhiyaman V, Kamalakannan D, Oke A, Shah IU, White AD (2000) Underutilization of antithrombotic therapy in atrial fibrillation. J R Soc Med 93:138-140
21. Flaker GC, McGowan DJ, Boechler M, Fortune G, Gage B (1999) Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. Am Heart J 137:307-312
22. Mendelson G, Aronow WS (1998) Underutilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke. J Am Geriatr Soc 46:1423-1424
23. Waldo AL, Becker RC, Tapson VF, Colgan KJ for the NABOR Steering Committee (2005) Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol 46:1729-1736
24. Berrettini M (1997) Anticoagulation clinics: the Italian experience. Haematologica 82:713-717
25. Kutner M, Nixon G, Silverstone F (1991) Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. Arch Intern Med 151:1950-1953
26. McCrory DC, Matchar DB, Samsa G, Sanders LL, Pritchett ELC ( 1995) Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med 155:277-281
27. Whittle J, Wickenheiser L, Venditti LN (1997) Is warfarin underused in the treatment of elderly persons with atrial fibrillation? Arch Intern Med 157:441-445
28. Monette J, Gurwitz JH, Rochon PA, Avorn J (1997) Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long- term care practitioners. J Am Geriatr Soc 45:1060-1065
29. Chang HJ, Bell JR, Devoo DB, Kirk JW, Wasson JH (1990) Physician variation in anticoagulating patients with atrial fibrillation. Arch Intern Med 150:81-84
30. Lip GYH, Zarifis J, Watson RDS, Beevers DG (1996) Physician variation in the management of patients with atrial fibrillation. Heart 75:200-205
31. Copland M, Walker ID, Campbell Tait RC (2001) Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation. Arch Intern Med 161:2125-2128
32. Man-Son-Hing M, Laupacis A (2003) Anticoagulant-related bleeding in older persons with atrial fibrillation. Physicians' fears often unfounded. Arch Intern Med 163:1580-1586
33. Rodgers H, Sudlow M, Dobson R, Kenny RA, Thomson RG (1997) Warfarin anticoagulation in primary care: a regional survey of present practice and clinicians' views. Br J Gen Pract 47:309-310